Richelle Candice Charles, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Typhoid Fever | 23 | 2024 | 195 | 5.770 |
Why?
|
Cholera | 44 | 2024 | 754 | 5.080 |
Why?
|
Antibodies, Bacterial | 46 | 2024 | 1478 | 4.580 |
Why?
|
Salmonella typhi | 20 | 2024 | 200 | 3.720 |
Why?
|
Vibrio cholerae O1 | 26 | 2024 | 243 | 3.700 |
Why?
|
O Antigens | 23 | 2024 | 196 | 3.120 |
Why?
|
Cholera Vaccines | 22 | 2024 | 264 | 2.770 |
Why?
|
Immunoglobulin A | 35 | 2024 | 992 | 2.450 |
Why?
|
Vibrio cholerae | 14 | 2023 | 793 | 1.780 |
Why?
|
Antigens, Bacterial | 10 | 2024 | 1150 | 1.510 |
Why?
|
Bangladesh | 36 | 2023 | 741 | 1.470 |
Why?
|
Immunoglobulin M | 25 | 2024 | 1528 | 1.340 |
Why?
|
Antibodies, Viral | 20 | 2023 | 3216 | 1.210 |
Why?
|
Paratyphoid Fever | 6 | 2022 | 34 | 1.190 |
Why?
|
Immunoglobulin G | 38 | 2024 | 4568 | 1.160 |
Why?
|
Vibrio cholerae O139 | 5 | 2023 | 54 | 1.040 |
Why?
|
Vaccines, Conjugate | 12 | 2024 | 334 | 0.860 |
Why?
|
Carrier State | 5 | 2024 | 529 | 0.770 |
Why?
|
Bartonella henselae | 1 | 2021 | 15 | 0.760 |
Why?
|
Salmonella enterica | 2 | 2024 | 76 | 0.760 |
Why?
|
Immunologic Memory | 13 | 2022 | 1378 | 0.760 |
Why?
|
Cat-Scratch Disease | 1 | 2021 | 23 | 0.750 |
Why?
|
Salmonella paratyphi A | 7 | 2024 | 47 | 0.750 |
Why?
|
Serologic Tests | 2 | 2020 | 383 | 0.730 |
Why?
|
Immunoassay | 3 | 2024 | 746 | 0.720 |
Why?
|
Immunity, Mucosal | 4 | 2020 | 498 | 0.710 |
Why?
|
Dysentery, Bacillary | 3 | 2024 | 73 | 0.650 |
Why?
|
Vaccination | 17 | 2024 | 3436 | 0.640 |
Why?
|
Magnetite Nanoparticles | 2 | 2017 | 313 | 0.600 |
Why?
|
Antibody Specificity | 1 | 2019 | 1065 | 0.550 |
Why?
|
Bacteremia | 7 | 2015 | 985 | 0.550 |
Why?
|
Immunity, Humoral | 5 | 2020 | 610 | 0.550 |
Why?
|
DNA Probes | 1 | 2016 | 543 | 0.500 |
Why?
|
Point-of-Care Systems | 2 | 2024 | 1240 | 0.500 |
Why?
|
Cholera Toxin | 12 | 2024 | 562 | 0.470 |
Why?
|
Shigella Vaccines | 2 | 2024 | 10 | 0.460 |
Why?
|
Antibodies, Neutralizing | 7 | 2022 | 2009 | 0.440 |
Why?
|
Salmonella | 4 | 2023 | 125 | 0.420 |
Why?
|
Antibody Formation | 8 | 2024 | 1393 | 0.420 |
Why?
|
Coronavirus Infections | 5 | 2020 | 3116 | 0.410 |
Why?
|
Biliary Tract | 1 | 2013 | 135 | 0.410 |
Why?
|
Pneumonia, Viral | 5 | 2020 | 3239 | 0.410 |
Why?
|
Lipopolysaccharides | 11 | 2024 | 2222 | 0.380 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2016 | 620 | 0.380 |
Why?
|
B-Lymphocytes | 11 | 2022 | 4794 | 0.360 |
Why?
|
Mucous Membrane | 3 | 2019 | 659 | 0.340 |
Why?
|
Vaccines, Inactivated | 8 | 2023 | 186 | 0.340 |
Why?
|
Sensitivity and Specificity | 11 | 2024 | 14751 | 0.330 |
Why?
|
Haiti | 9 | 2023 | 553 | 0.330 |
Why?
|
Typhoid-Paratyphoid Vaccines | 2 | 2020 | 40 | 0.330 |
Why?
|
Bacterial Proteins | 5 | 2014 | 3839 | 0.330 |
Why?
|
Lymphocytes | 3 | 2022 | 2614 | 0.330 |
Why?
|
Lymph Nodes | 1 | 2021 | 3473 | 0.330 |
Why?
|
Shigella flexneri | 3 | 2024 | 118 | 0.320 |
Why?
|
Antibodies, Monoclonal | 3 | 2021 | 9264 | 0.320 |
Why?
|
Disease Outbreaks | 6 | 2018 | 1761 | 0.310 |
Why?
|
Child, Preschool | 29 | 2024 | 42684 | 0.300 |
Why?
|
Cross Reactions | 5 | 2022 | 828 | 0.300 |
Why?
|
Interferon-gamma | 2 | 2014 | 3163 | 0.300 |
Why?
|
Host-Pathogen Interactions | 2 | 2014 | 1469 | 0.300 |
Why?
|
Antibody-Producing Cells | 5 | 2021 | 140 | 0.290 |
Why?
|
Salmonella typhimurium | 1 | 2009 | 348 | 0.280 |
Why?
|
Leukocytes, Mononuclear | 4 | 2017 | 1855 | 0.280 |
Why?
|
Clinical Laboratory Techniques | 3 | 2020 | 749 | 0.270 |
Why?
|
Neuraminidase | 3 | 2022 | 196 | 0.260 |
Why?
|
Humans | 104 | 2024 | 768887 | 0.260 |
Why?
|
Child | 35 | 2024 | 80969 | 0.250 |
Why?
|
Adult | 52 | 2024 | 223818 | 0.250 |
Why?
|
Shigella sonnei | 1 | 2024 | 7 | 0.240 |
Why?
|
Seroepidemiologic Studies | 5 | 2024 | 405 | 0.240 |
Why?
|
Young Adult | 29 | 2024 | 60110 | 0.240 |
Why?
|
Vaccines, Combined | 2 | 2021 | 70 | 0.230 |
Why?
|
Adolescent | 31 | 2024 | 89247 | 0.220 |
Why?
|
Proteome | 1 | 2013 | 1891 | 0.220 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2009 | 1137 | 0.220 |
Why?
|
Endemic Diseases | 1 | 2024 | 190 | 0.210 |
Why?
|
Shigella | 1 | 2023 | 69 | 0.210 |
Why?
|
Communicable Diseases | 2 | 2024 | 873 | 0.200 |
Why?
|
Urine | 2 | 2021 | 362 | 0.200 |
Why?
|
Cytokines | 4 | 2020 | 7453 | 0.200 |
Why?
|
Cholecystectomy | 1 | 2024 | 409 | 0.200 |
Why?
|
Blood Group Antigens | 1 | 2023 | 185 | 0.190 |
Why?
|
Proteomics | 4 | 2022 | 3913 | 0.190 |
Why?
|
Administration, Oral | 10 | 2021 | 4042 | 0.190 |
Why?
|
Zingiberales | 1 | 2000 | 1 | 0.190 |
Why?
|
Guaiacol | 1 | 2000 | 5 | 0.190 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2020 | 3814 | 0.190 |
Why?
|
Agglutination | 1 | 2020 | 42 | 0.180 |
Why?
|
Flank Pain | 1 | 2021 | 44 | 0.180 |
Why?
|
Polymerase Chain Reaction | 3 | 2021 | 6085 | 0.180 |
Why?
|
Animals, Suckling | 1 | 2020 | 69 | 0.180 |
Why?
|
Immunoglobulin Isotypes | 1 | 2021 | 158 | 0.180 |
Why?
|
Tetanus Toxin | 2 | 2023 | 46 | 0.180 |
Why?
|
Sanitation | 2 | 2011 | 83 | 0.180 |
Why?
|
Female | 53 | 2024 | 397464 | 0.180 |
Why?
|
Chromatography, Affinity | 3 | 2024 | 525 | 0.180 |
Why?
|
Nucleocapsid Proteins | 1 | 2020 | 75 | 0.180 |
Why?
|
Carotid Artery Injuries | 1 | 2000 | 96 | 0.170 |
Why?
|
Middle Aged | 37 | 2024 | 223740 | 0.170 |
Why?
|
Interleukin-23 Subunit p19 | 1 | 2019 | 23 | 0.170 |
Why?
|
Cats | 1 | 2021 | 978 | 0.170 |
Why?
|
Male | 48 | 2024 | 365249 | 0.160 |
Why?
|
Ceramides | 1 | 2000 | 203 | 0.160 |
Why?
|
Klebsiella pneumoniae | 1 | 2021 | 253 | 0.160 |
Why?
|
Feces | 5 | 2018 | 1511 | 0.160 |
Why?
|
Gallbladder | 2 | 2024 | 308 | 0.150 |
Why?
|
Immune Evasion | 1 | 2022 | 376 | 0.150 |
Why?
|
Nausea | 1 | 2021 | 682 | 0.150 |
Why?
|
Phosphotransferases (Nitrogenous Group Acceptor) | 1 | 2017 | 5 | 0.150 |
Why?
|
Reproducibility of Results | 4 | 2020 | 20244 | 0.150 |
Why?
|
Pakistan | 3 | 2024 | 298 | 0.140 |
Why?
|
Phosphoenolpyruvate Sugar Phosphotransferase System | 1 | 2017 | 23 | 0.140 |
Why?
|
Viral Load | 3 | 2022 | 3398 | 0.140 |
Why?
|
Diarrhea | 3 | 2023 | 1319 | 0.140 |
Why?
|
Receptors, IgG | 1 | 2020 | 564 | 0.140 |
Why?
|
Fever | 2 | 2023 | 1620 | 0.140 |
Why?
|
Infant | 11 | 2023 | 36541 | 0.140 |
Why?
|
Pandemics | 10 | 2023 | 8745 | 0.140 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2019 | 394 | 0.140 |
Why?
|
Bacteriological Techniques | 1 | 2018 | 277 | 0.140 |
Why?
|
Flagellin | 1 | 2017 | 124 | 0.140 |
Why?
|
Escherichia coli | 2 | 2021 | 4212 | 0.130 |
Why?
|
Antigens, Viral | 1 | 2020 | 996 | 0.130 |
Why?
|
Immunity, Innate | 2 | 2019 | 3080 | 0.130 |
Why?
|
Bayes Theorem | 3 | 2023 | 2357 | 0.130 |
Why?
|
Immunologic Tests | 1 | 2016 | 104 | 0.120 |
Why?
|
General Practitioners | 1 | 2016 | 103 | 0.120 |
Why?
|
Cohort Studies | 9 | 2022 | 41800 | 0.120 |
Why?
|
Travel | 1 | 2021 | 805 | 0.120 |
Why?
|
Bacterial Shedding | 1 | 2014 | 10 | 0.120 |
Why?
|
Plasma | 1 | 2018 | 585 | 0.120 |
Why?
|
Mice | 15 | 2024 | 82074 | 0.110 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2018 | 591 | 0.110 |
Why?
|
HIV Antibodies | 1 | 2020 | 1341 | 0.110 |
Why?
|
Bacterial Load | 1 | 2014 | 154 | 0.110 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2000 | 1724 | 0.110 |
Why?
|
Microspheres | 1 | 2016 | 789 | 0.110 |
Why?
|
Blood Bactericidal Activity | 4 | 2015 | 124 | 0.110 |
Why?
|
RNA | 1 | 2023 | 2727 | 0.100 |
Why?
|
Animals | 17 | 2024 | 169408 | 0.100 |
Why?
|
Biosensing Techniques | 2 | 2017 | 662 | 0.100 |
Why?
|
RNA, Bacterial | 2 | 2011 | 393 | 0.100 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2015 | 340 | 0.100 |
Why?
|
Nucleic Acids | 1 | 2015 | 189 | 0.100 |
Why?
|
Blood | 2 | 2016 | 597 | 0.100 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2015 | 481 | 0.100 |
Why?
|
Nepal | 1 | 2013 | 301 | 0.100 |
Why?
|
Protein Array Analysis | 1 | 2013 | 400 | 0.100 |
Why?
|
Immunologic Factors | 1 | 2021 | 1597 | 0.100 |
Why?
|
T-Lymphocytes | 5 | 2021 | 10276 | 0.090 |
Why?
|
Hemolysin Proteins | 2 | 2024 | 113 | 0.090 |
Why?
|
Bacteriophages | 1 | 2014 | 382 | 0.090 |
Why?
|
Species Specificity | 3 | 2015 | 2419 | 0.090 |
Why?
|
Severity of Illness Index | 4 | 2022 | 15955 | 0.090 |
Why?
|
Virulence | 2 | 2014 | 1298 | 0.090 |
Why?
|
Gene Expression Profiling | 4 | 2018 | 9549 | 0.080 |
Why?
|
Monocytes | 1 | 2019 | 2603 | 0.080 |
Why?
|
Oligosaccharides | 1 | 2012 | 407 | 0.080 |
Why?
|
Immunization, Secondary | 3 | 2021 | 373 | 0.080 |
Why?
|
Water Supply | 1 | 2010 | 204 | 0.080 |
Why?
|
Rabbits | 3 | 2023 | 4774 | 0.080 |
Why?
|
Weight Loss | 1 | 2021 | 2720 | 0.080 |
Why?
|
Bacterial Infections | 1 | 2017 | 1397 | 0.080 |
Why?
|
Epidemics | 1 | 2014 | 517 | 0.080 |
Why?
|
Anti-Bacterial Agents | 3 | 2018 | 7472 | 0.070 |
Why?
|
Vaccines | 1 | 2016 | 842 | 0.070 |
Why?
|
RNA, Messenger | 4 | 2016 | 12809 | 0.070 |
Why?
|
Diagnostic Tests, Routine | 1 | 2013 | 790 | 0.070 |
Why?
|
Fluorescent Dyes | 1 | 2015 | 1933 | 0.070 |
Why?
|
Disease Models, Animal | 7 | 2023 | 18366 | 0.070 |
Why?
|
Bacterial Vaccines | 1 | 2009 | 400 | 0.070 |
Why?
|
Leptin | 1 | 2015 | 1597 | 0.070 |
Why?
|
Genes, Bacterial | 1 | 2010 | 1076 | 0.070 |
Why?
|
Asia | 2 | 2018 | 629 | 0.070 |
Why?
|
Fluid Therapy | 1 | 2010 | 587 | 0.070 |
Why?
|
Antitoxins | 2 | 2019 | 75 | 0.070 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2016 | 3782 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4651 | 0.060 |
Why?
|
Reagent Kits, Diagnostic | 2 | 2018 | 239 | 0.060 |
Why?
|
Epitopes | 2 | 2022 | 2529 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 13020 | 0.060 |
Why?
|
Single-Cell Analysis | 1 | 2016 | 2542 | 0.060 |
Why?
|
Biosurveillance | 1 | 2024 | 16 | 0.060 |
Why?
|
Administration, Cutaneous | 2 | 2020 | 716 | 0.060 |
Why?
|
Genetic Variation | 2 | 2017 | 6610 | 0.060 |
Why?
|
Massachusetts | 3 | 2023 | 8888 | 0.060 |
Why?
|
T-Lymphocyte Subsets | 1 | 2012 | 1813 | 0.060 |
Why?
|
Mice, Inbred BALB C | 2 | 2024 | 6232 | 0.060 |
Why?
|
Retrospective Studies | 5 | 2024 | 81892 | 0.060 |
Why?
|
Aged | 9 | 2024 | 171790 | 0.050 |
Why?
|
Disease Progression | 1 | 2020 | 13677 | 0.050 |
Why?
|
Lymphocyte Activation | 1 | 2014 | 5505 | 0.050 |
Why?
|
Cells, Cultured | 3 | 2013 | 19023 | 0.050 |
Why?
|
Gallbladder Diseases | 1 | 2024 | 139 | 0.050 |
Why?
|
Mass Spectrometry | 1 | 2010 | 2204 | 0.050 |
Why?
|
Enterotoxins | 2 | 2016 | 365 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2016 | 3925 | 0.050 |
Why?
|
Th17 Cells | 2 | 2022 | 791 | 0.050 |
Why?
|
Cross-Sectional Studies | 5 | 2024 | 26384 | 0.050 |
Why?
|
Phosphoproteins | 2 | 2020 | 2452 | 0.050 |
Why?
|
Evolution, Molecular | 2 | 2022 | 1894 | 0.050 |
Why?
|
Peru | 1 | 2024 | 891 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2014 | 4413 | 0.050 |
Why?
|
Family Characteristics | 2 | 2018 | 1002 | 0.050 |
Why?
|
Convalescence | 1 | 2021 | 109 | 0.050 |
Why?
|
France | 3 | 2016 | 497 | 0.050 |
Why?
|
Binding Sites, Antibody | 1 | 2021 | 340 | 0.050 |
Why?
|
Escape Reaction | 1 | 2000 | 57 | 0.050 |
Why?
|
Intubation | 1 | 2020 | 140 | 0.040 |
Why?
|
Territoriality | 1 | 1999 | 6 | 0.040 |
Why?
|
Plants, Medicinal | 1 | 2000 | 167 | 0.040 |
Why?
|
Asymptomatic Infections | 1 | 2021 | 135 | 0.040 |
Why?
|
HL-60 Cells | 1 | 2020 | 364 | 0.040 |
Why?
|
Limit of Detection | 1 | 2020 | 277 | 0.040 |
Why?
|
Genome, Bacterial | 2 | 2018 | 796 | 0.040 |
Why?
|
Diazepam | 1 | 2000 | 214 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2022 | 425 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2017 | 22294 | 0.040 |
Why?
|
Exploratory Behavior | 1 | 2000 | 276 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 622 | 0.040 |
Why?
|
Vocalization, Animal | 1 | 1999 | 95 | 0.040 |
Why?
|
Immunization Schedule | 1 | 2020 | 228 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 4593 | 0.040 |
Why?
|
Macaca fascicularis | 1 | 2021 | 913 | 0.040 |
Why?
|
Bacterial Toxins | 2 | 2016 | 921 | 0.040 |
Why?
|
Hospitalization | 4 | 2021 | 10845 | 0.040 |
Why?
|
Avoidance Learning | 1 | 2000 | 249 | 0.040 |
Why?
|
Biotechnology | 1 | 2020 | 283 | 0.040 |
Why?
|
Coronavirus | 1 | 2020 | 156 | 0.040 |
Why?
|
Africa South of the Sahara | 1 | 2021 | 752 | 0.040 |
Why?
|
Tunica Intima | 1 | 2000 | 459 | 0.040 |
Why?
|
Anti-Anxiety Agents | 1 | 2000 | 405 | 0.040 |
Why?
|
Transgenes | 1 | 2021 | 1016 | 0.040 |
Why?
|
Glycosylation | 1 | 2020 | 1101 | 0.040 |
Why?
|
Escherichia coli Proteins | 2 | 2016 | 1058 | 0.040 |
Why?
|
Cryoelectron Microscopy | 1 | 2022 | 649 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20776 | 0.040 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2021 | 336 | 0.040 |
Why?
|
Polysaccharides, Bacterial | 1 | 2020 | 582 | 0.040 |
Why?
|
Peptides | 1 | 2009 | 4353 | 0.040 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2021 | 238 | 0.040 |
Why?
|
Phylogeny | 2 | 2018 | 2843 | 0.040 |
Why?
|
Protein Subunits | 1 | 2020 | 943 | 0.040 |
Why?
|
Crystallography, X-Ray | 1 | 2022 | 1952 | 0.040 |
Why?
|
Hyperplasia | 1 | 2000 | 1154 | 0.030 |
Why?
|
Acute Disease | 2 | 2018 | 7245 | 0.030 |
Why?
|
Plant Extracts | 1 | 2000 | 499 | 0.030 |
Why?
|
Gene Transfer, Horizontal | 1 | 2017 | 148 | 0.030 |
Why?
|
Microbiological Techniques | 1 | 1977 | 97 | 0.030 |
Why?
|
Hybridomas | 1 | 2017 | 444 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15662 | 0.030 |
Why?
|
Dependovirus | 1 | 2021 | 721 | 0.030 |
Why?
|
North America | 1 | 2019 | 1290 | 0.030 |
Why?
|
Oxides | 1 | 2017 | 403 | 0.030 |
Why?
|
Africa | 1 | 2018 | 726 | 0.030 |
Why?
|
Age Factors | 3 | 2021 | 18454 | 0.030 |
Why?
|
Immunization Programs | 1 | 2018 | 267 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2022 | 14795 | 0.030 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2021 | 621 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2000 | 1246 | 0.030 |
Why?
|
Fluorescence Polarization | 1 | 2015 | 139 | 0.030 |
Why?
|
Public Health | 2 | 2023 | 2680 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2020 | 59738 | 0.030 |
Why?
|
Polysaccharides | 1 | 2022 | 1024 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 1003 | 0.030 |
Why?
|
Fungi | 1 | 1977 | 345 | 0.030 |
Why?
|
Duodenum | 1 | 2018 | 495 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2020 | 941 | 0.030 |
Why?
|
Signal Transduction | 1 | 2018 | 23652 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2021 | 2365 | 0.030 |
Why?
|
Stress, Psychological | 2 | 2000 | 4542 | 0.030 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 2014 | 85 | 0.030 |
Why?
|
Mutation | 3 | 2022 | 30266 | 0.030 |
Why?
|
Survival Analysis | 2 | 2020 | 10115 | 0.030 |
Why?
|
Adhesins, Bacterial | 1 | 2014 | 118 | 0.030 |
Why?
|
Models, Biological | 2 | 2009 | 9499 | 0.030 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2000 | 1493 | 0.030 |
Why?
|
Social Behavior | 1 | 2000 | 1146 | 0.030 |
Why?
|
Microbial Viability | 1 | 2015 | 235 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3346 | 0.030 |
Why?
|
Zinc | 1 | 2017 | 678 | 0.030 |
Why?
|
Language | 1 | 2023 | 1559 | 0.030 |
Why?
|
Prophages | 1 | 2013 | 39 | 0.030 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2017 | 446 | 0.030 |
Why?
|
Carotid Stenosis | 1 | 2000 | 862 | 0.030 |
Why?
|
Hot Temperature | 1 | 2019 | 1440 | 0.030 |
Why?
|
Plasmids | 1 | 2017 | 2269 | 0.030 |
Why?
|
Point Mutation | 1 | 2017 | 1595 | 0.030 |
Why?
|
History, 21st Century | 1 | 2018 | 1575 | 0.030 |
Why?
|
Antibodies | 1 | 2020 | 2422 | 0.030 |
Why?
|
Haplotypes | 1 | 2018 | 2725 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2024 | 26394 | 0.020 |
Why?
|
Time Factors | 3 | 2020 | 40266 | 0.020 |
Why?
|
Colony Count, Microbial | 1 | 2012 | 328 | 0.020 |
Why?
|
Cell Separation | 1 | 2017 | 1728 | 0.020 |
Why?
|
Genomics | 2 | 2018 | 5928 | 0.020 |
Why?
|
Models, Molecular | 1 | 2022 | 5404 | 0.020 |
Why?
|
Immunization | 1 | 2015 | 1219 | 0.020 |
Why?
|
Rehydration Solutions | 1 | 2010 | 43 | 0.020 |
Why?
|
Erythromycin | 1 | 2010 | 115 | 0.020 |
Why?
|
Vaccines, Attenuated | 1 | 2012 | 313 | 0.020 |
Why?
|
History, 20th Century | 1 | 2018 | 2771 | 0.020 |
Why?
|
Caribbean Region | 1 | 2010 | 193 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2012 | 687 | 0.020 |
Why?
|
History, 18th Century | 1 | 2010 | 206 | 0.020 |
Why?
|
Serotyping | 1 | 2010 | 332 | 0.020 |
Why?
|
Tetracycline | 1 | 2010 | 216 | 0.020 |
Why?
|
Protein Binding | 1 | 2022 | 9344 | 0.020 |
Why?
|
Latin America | 1 | 2010 | 416 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8742 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5323 | 0.020 |
Why?
|
Mice, Inbred DBA | 2 | 2000 | 624 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2019 | 11934 | 0.020 |
Why?
|
Iron | 1 | 2017 | 1813 | 0.020 |
Why?
|
Neutrophils | 1 | 2022 | 3785 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2014 | 2695 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2015 | 2598 | 0.020 |
Why?
|
Doxycycline | 1 | 2010 | 349 | 0.020 |
Why?
|
Biological Evolution | 1 | 2014 | 1078 | 0.020 |
Why?
|
Age Distribution | 1 | 2014 | 2875 | 0.020 |
Why?
|
HIV Infections | 1 | 2015 | 17589 | 0.020 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 22381 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9375 | 0.020 |
Why?
|
Malnutrition | 1 | 2014 | 631 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2010 | 755 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2015 | 10486 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2010 | 1990 | 0.020 |
Why?
|
Th1 Cells | 1 | 2012 | 1042 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2020 | 3800 | 0.020 |
Why?
|
Hospitals | 1 | 2020 | 3903 | 0.020 |
Why?
|
Th2 Cells | 1 | 2012 | 1079 | 0.020 |
Why?
|
Adjuvants, Immunologic | 1 | 2012 | 999 | 0.020 |
Why?
|
Bacteria | 1 | 1977 | 2219 | 0.020 |
Why?
|
Incidence | 2 | 2022 | 21545 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10591 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6805 | 0.020 |
Why?
|
Mammography | 1 | 1997 | 2434 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2010 | 2231 | 0.020 |
Why?
|
Base Sequence | 1 | 2015 | 12430 | 0.010 |
Why?
|
World Health Organization | 1 | 2010 | 1327 | 0.010 |
Why?
|
Apoptosis | 1 | 2000 | 9528 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6512 | 0.010 |
Why?
|
Mass Screening | 2 | 1997 | 5455 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2018 | 12469 | 0.010 |
Why?
|
United States | 2 | 2024 | 73180 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2014 | 3047 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3811 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4862 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2015 | 5544 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2010 | 4624 | 0.010 |
Why?
|
Risk Factors | 2 | 2022 | 74971 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12093 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 30044 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2010 | 4784 | 0.010 |
Why?
|
Breast Neoplasms | 2 | 1997 | 21187 | 0.010 |
Why?
|
Ultrasonics | 1 | 1999 | 208 | 0.010 |
Why?
|
Urination | 1 | 1999 | 204 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2000 | 15889 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 9618 | 0.010 |
Why?
|
Culture Media | 1 | 1977 | 898 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1977 | 1629 | 0.010 |
Why?
|
Aggression | 1 | 1999 | 750 | 0.010 |
Why?
|
Transcription Factors | 1 | 2014 | 12174 | 0.010 |
Why?
|
Social Environment | 1 | 1999 | 1016 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 65485 | 0.010 |
Why?
|
Liver | 1 | 1989 | 7579 | 0.010 |
Why?
|
Cross-Cultural Comparison | 1 | 1997 | 638 | 0.010 |
Why?
|
Glutamate-Ammonia Ligase | 1 | 1989 | 76 | 0.010 |
Why?
|
Program Evaluation | 1 | 1996 | 2507 | 0.000 |
Why?
|
Data Collection | 1 | 1997 | 3322 | 0.000 |
Why?
|
Quality Assurance, Health Care | 1 | 1997 | 2181 | 0.000 |
Why?
|
Models, Anatomic | 1 | 1989 | 683 | 0.000 |
Why?
|
Anxiety | 1 | 2000 | 4677 | 0.000 |
Why?
|
Tissue Distribution | 1 | 1989 | 2299 | 0.000 |
Why?
|
Staining and Labeling | 1 | 1989 | 1081 | 0.000 |
Why?
|
Referral and Consultation | 1 | 1997 | 3626 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1989 | 11119 | 0.000 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1989 | 9081 | 0.000 |
Why?
|